NCT00034593已完成2 期
A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 10
研究概览
简要总结
Definition: Patients with bladder cancer will be participating in this study for the treatment of abnormal cells in the bladder that have returned after initial treatment OR have moved to a new site in the body.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •You must have been diagnosed with bladder cancer that has recurred or moved to a new part of the body.
- •You must have at least one tumor that can be physically measured or scanned by x-ray.
- •You may not have had previous chemotherapy (drug) treatment OR you have had surgery followed by one chemotherapy treatment at least 4 months ago.
排除标准
- •You may not have used an experimental medicine or device within the past month.
- •Cancer that has spread to your brain.
- •If you are unwilling or unable to take folic acid or vitamin B12 supplements.
研究者
研究点 (10)
Loading locations...
相似试验
已完成
2 期
A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the UrotheliumUrologic NeoplasmsMetastases, NeoplasmNCT00035061Eli Lilly and Company
终止
2 期
Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder CancerUrinary Bladder NeoplasmsNCT02560038The University of Texas Health Science Center, Houston3
已完成
2 期
A Trial for Patients With Advanced/Recurrent Cervical CancerUterine NeoplasmsGenital Neoplasms, FemaleCervical Intraepithelial NeoplasiaNCT00190983Eli Lilly and Company29
已完成
2 期
Pemetrexed as the First Treatment in Advanced or Metastatic Breast CancerBreast Neoplasms, MaleCarcinoma, DuctalBreast CancerNCT00106002Eli Lilly and Company37
已完成
2 期
Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is MetastaticPancreatic CancerNCT00490373Eli Lilly and Company52